EP. 1: Treatment Selection and Sequencing in Third Line Settings and Beyond
EP. 2: Understanding Janet's Journey: Navigating HER2+ Metastatic Breast Cancer & Treatment Options
EP. 3: Exploring Third-Line Options in HER2+ mBC: Janet’s Case & Key Trial Insights from HER2CLIMB and EMILIA
Dr O’Shaughnessy leads a panel of medical experts in a discussion around a patient case surrounding findings from HER2CLIMB and EMILIA clinical trials.
